Concerns are rising as Novo Nordisk's $16.5 billion bid to acquire Catalent faces scrutiny from the FTC. Critics argue the ...
Senate Democrat Elizabeth Warren urges the Federal Trade Commission to closely scrutinize a proposed merger between Novo Nordisk and contract development and manufacturing organization Catalent, ...
Earnings Estimate Revisions for Catalent For the fiscal year ending June 2025, this maker of drug delivery technologies is expected to earn $1.36 per share, which is a change of 444% from the year ...
Whales with a lot of money to spend have taken a noticeably bearish stance on Danaher. Looking at options history for Danaher DHR we detected 38 trades. If we consider the specifics of each trade ...
Catalent, Inc. CTLT reported fourth-quarter fiscal 2024 adjusted earnings per share (EPS) of 65 cents, which was significantly up from the year-ago period’s EPS of 2 cents. The figure surpassed ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
In NBA 2K25, Takeover is a powerful mechanic that allows a player to gain momentum and dominate the game when performing well. It enhances key attributes, making it easier to hit tough shots ...
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The valuation of social media platform X has dropped dramatically in the eyes of major investment firm Fidelity, according to multiple reports. The market value of Fidelity Blue Chip Growth Fund's ...
Investors might want to bet on Catalent (CTLT), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...
SOMERSET, N.J., August 29, 2024--Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced financial results for ...